Mai Capital Management Cyto Dyn Inc. Transaction History
Mai Capital Management
- $9.87 Billion
- Q2 2024
A detailed history of Mai Capital Management transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Mai Capital Management holds 42,482 shares of CYDY stock, worth $6,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,482
Previous 42,482
-0.0%
Holding current value
$6,372
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CYDY
# of Institutions
12Shares Held
271KCall Options Held
0Put Options Held
0-
Diversified Trust CO45.8KShares$6,8680.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$6,7500.0% of portfolio
-
Moloney Securities Asset Management, LLC28KShares$4,2030.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY25KShares$3,7500.0% of portfolio
-
S.A. Mason LLC19KShares$2,8500.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $122M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...